Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
Lukas Hobohm, Ingo Sagoschen, Stefano Barco, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 275-275
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101
Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, et al.
Science Advances (2022) Vol. 8, Iss. 33
Open Access | Times Cited: 41
Drivers and recent trends of hospitalisation costs related to acute pulmonary embolism
Katharina Mohr, Lukas Hobohm, Klaus Kaier, et al.
Clinical Research in Cardiology (2024)
Open Access | Times Cited: 9
COVID-19 infection and its impact on case fatality in patients with pulmonary embolism
Lukas Hobohm, Ingo Sagoschen, Stefano Barco, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200619-2200619
Open Access | Times Cited: 34
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Roland Linder, Jonas Peltner, A. Astvatsatourov, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
COVID-19 Disease Burden in the Omicron Variant-Dominated Endemic Phase: Insights from the ROUTINE-COV19 Study Using Real-World German Statutory Health Insurance Data
S. Mueller, A Schmetz, Julia K. Knaul, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 424-424
Open Access
Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area
Davide Voci, Ugo Fedeli, Ioannis T. Farmakis, et al.
Thrombosis Research (2022) Vol. 212, pp. 44-50
Open Access | Times Cited: 23
Incidence and risk factors of myocarditis in hospitalized patients with COVID‐19
Karsten Keller, Ingo Sagoschen, Stavros Konstantinides, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 14
The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene TLR4 as a protective factor in corona virus disease 2019 (COVID-19)
Christoph Zacher, Kristina Schönfelder, Hana Rohn, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Obesity and Its Impact on Adverse In-Hospital Outcomes in Hospitalized Patients With COVID-19
Karsten Keller, Ingo Sagoschen, Volker H. Schmitt, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Predisposing factors for admission to intensive care units of patients with COVID-19 infection—Results of the German nationwide inpatient sample
Karsten Keller, Ioannis T. Farmakis, Luca Valerio, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 10
From acute SARS-CoV-2 infection to pulmonary hypertension
Emmanuel Eroume À Egom, Haaris A. Shiwani, Brice Nouthe
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 14
Early warning of potential epidemics: A pilot application of an early warning tool to data from the pulmonary clinic of the university hospital of Thessaly, Greece
Eleftherios Meletis, Irene Poulakida, Garyfallia Perlepe, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 3, pp. 401-405
Open Access | Times Cited: 2
Former SARS-CoV-2 Infection Was Related to Decreased VO2 Peak and Exercise Hypertension in Athletes
Karsten Keller, Oliver Friedrich, Julia Treiber, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1792-1792
Open Access | Times Cited: 6
Clinical characteristics and predictors for in-hospital mortality in adult COVID-19 patients: A retrospective single center cohort study in Vilnius, Lithuania
Ieva Kubiliute, Monika Vitkauskaitė, Jurgita Urbonienė, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290656-e0290656
Open Access | Times Cited: 6
Temporal Trends in Patients with Peripheral Artery Disease Influenced by COVID-19 Pandemic
Karsten Keller, Volker H. Schmitt, Lukas Hobohm, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6433-6433
Open Access | Times Cited: 9
Impact of public health and social measures for COVID-19 control on infectious disease epidemiology

Frontiers research topics (2024)
Open Access | Times Cited: 1
Association between socioeconomic and psychosocial factors with use of interventional and surgical treatments and outcomes in patients with myocardial infarction – Inpatient data of the largest European health care system
Omar Hahad, Lukas Hobohm, Sadeer Al‐Kindi, et al.
European Journal of Internal Medicine (2024) Vol. 128, pp. 71-80
Open Access | Times Cited: 1
Intensive Care Treatment in Acute Pulmonary Embolism in Germany, 2016 to 2020: A Nationwide Inpatient Database Study
Karsten Keller, Ingo Sagoschen, Ioannis T. Farmakis, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 6, pp. 102545-102545
Open Access | Times Cited: 1
Case Fatality of Hospitalized Patients with COVID-19 Infection Suffering from Acute Respiratory Distress Syndrome in Germany
Ingo Sagoschen, Karsten Keller, Johannes Wild, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2515-2515
Open Access | Times Cited: 8
The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)
Birte Möhlendick, Kristina Schönfelder, Christoph Zacher, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
Ioannis T. Farmakis, George Giannakoulas
Heart Failure Clinics (2022) Vol. 19, Iss. 1, pp. 107-114
Open Access | Times Cited: 7
Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis
Fatema Alrashed, Hajer Alasfour, Mohammad Shehab
JGH Open (2022) Vol. 6, Iss. 4, pp. 241-250
Open Access | Times Cited: 6
Lungenembolie
Lukas Hobohm, Karsten Keller, Stavros Konstantinides
Deleted Journal (2023) Vol. 64, Iss. 1, pp. 40-49
Open Access | Times Cited: 3
Modeling mortality risk in patients with severe COVID-19 from Mexico
Arturo Cortés-Télles, Esperanza Figueroa‐Hurtado, Diana Lizbeth Ortíz‐Farias, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Diabetes Mellitus and Its Association with Adverse In-Hospital Outcomes in Patients with COVID-19—A Nationwide Study
Volker H. Schmitt, Lukas Hobohm, Ingo Sagoschen, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1627-1627
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top